Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Merck unveils early global access plan for monthly HIV prevention pill ahead of phase 3 completion
14+ hour, 48+ min ago (98+ words) Indian Pharma Post Merck unveils early global access plan for monthly HIV prevention pill ahead of phase 3 completion Merck said its strategy combines early generic licensing, regional manufacturing partnerships in Africa and Latin America The Business of Genomics Opportunities, Investments,…...
Sanofi rejigs top leadership team as it prepares for next strategic chapter
16+ hour, 2+ min ago (103+ words) Indian Pharma Post Sanofi rejigs top leadership team as it prepares for next strategic chapter Sanofi said Emmanuel Frenehard, Head of Digital, and Audrey Duval, Head of Corporate Affairs and President of Sanofi France, will continue reporting directly to Chief…...
Roche posts 6% growth as pipeline momentum accelerates, confirms 2026 outlook
20+ hour, 48+ min ago (72+ words) Indian Pharma Post Roche posts 6% growth as pipeline momentum accelerates, confirms 2026 outlook The Business of Genomics Opportunities, Investments, and Innovation in India Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical…...
TSI receives Turkish regulatory authorization to initiate Phase 2 PROMPT-STEMI trial
21+ hour, 28+ min ago (253+ words) The study is sponsored by TSI Biyoteknoloji ve İlaç A.Ş. (TSI Türkiye), a wholly owned subsidiary of TSI. The authorization permits the study to commence at the clinical centers included in the approved application. "Heart attacks remain a global health…...
Thermo Fisher reports 10% revenue growth in Q2, raises FY26 outlook
20+ hour, 56+ min ago (350+ words) Life sciences giant posts USD 11.99 billion in quarterly revenue, beats analyst estimates and lifts full-year revenue and profit guidance Thermo Fisher Scientific reported Q2 2026 revenue of USD 11.99 billion, up 10% year-on-year from USD 10.85 billion, prompting the company to raise its full-year 2026 revenue…...
GSK wins FDA approval for Jideytro after Nuvalent acquisition
1+ day, 19+ min ago (340+ words) ROS1-targeted therapy becomes GSK's first marketed lung cancer drug, expanding its oncology portfolio GSK has received US Food and Drug Administration (FDA) approval for Jideytro (zidesamtinib), a targeted therapy for patients with ROS1-positive non-small cell lung cancer (NSCLC), just days…...
Indian pharma manufacturers are expanding healthcare access across emerging markets: Saurabh Agarwal, Director, HAB Pharma
1+ day, 52+ min ago (63+ words) India did not become the pharmacy of the world by accident and sustaining that position will require continued commitment and long-term investment Saurabh Agarwal, Director, HAB Pharma Dr. Upasana Arora represents India's healthcare sector at Business Forum România–India OneSource…...
Aurobindo Pharma signs voluntary licensing pact with MSD to manufacture alimatravir
1+ day, 28+ min ago (328+ words) Royalty-free agreement covers supply of generic HIV prevention drug to 129 low- and middle-income countries, subject to regulatory approvals Aurobindo Pharma Limited has entered into a non-exclusive voluntary licensing agreement with MSD (the trade name of Merck & Co., Inc., Rahway, New…...
Govt strengthens ethical pharma marketing framework under revised UCPMP
1+ day, 19+ hour ago (146+ words) The Department of Pharmaceuticals (DoP) has strengthened the regulatory framework for ethical pharmaceutical marketing through the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024, which was notified on March 12, 2024, replacing the earlier UCPMP, 2015. As per the Minister of State for Chemicals…...
Apollo TeleHealth's Keonjhar Digital Dispensary Initiative crosses 1 million teleconsultations
1+ day, 19+ hour ago (240+ words) Apollo TeleHealth has surpassed one million teleconsultations through its Keonjhar Digital Dispensary Initiative, marking a major milestone in delivering quality primary healthcare to remote tribal, Particularly Vulnerable Tribal Group (PVTG), and mining communities in Odisha. Implemented in partnership with the…...